4‐Hydroxynonenal and cell cycle

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Biofactors

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/biof.5520240118PMID 16403975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line.

  2005cited by this paper
• 4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway.

  2004cited by this paper
• Resveratrol protects against 4‐HNE induced oxidative stress and apoptosis in Swiss 3T3 fibroblasts

  2004cited by this paper
• 4-hydroxynonenal and transforming growth factor-beta1 expression in colon cancer.

  2003cited by this paper
• 4-hydroxynonenal from pathology to physiology.

  2003cited by this paper
• E2F and cell cycle control: a double-edged sword.

  2003cited by this paper
• Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation.

  2002cited by this paper
• Cellular lipid peroxidation end-products induce apoptosis in human lens epithelial cells.

  2002cited by this paper
• Cytotoxic and cytostatic effects induced by 4-hydroxynonenal in human osteosarcoma cells.

  2002cited by this paper
• JNK3 contributes to c‐jun induction and apoptosis in 4‐hydroxynonenal‐treated sympathetic neurons

  2002cited by this paper
• 4-Hydroxynonenal affects pRb/E2F pathway in HL-60 human leukemic cells.

  2002cited by this paper
• Growth inhibition and differentiation induction in murine erythroleukemia cells by 4-hydroxynonenal

  2001cited by this paper
• Nuclear Factor-κB Blockade Attenuates but Does Not Abrogate Lipopolysaccharide-Dependent Tumor Necrosis Factor-α Biosynthesis in Alveolar Epithelial Cells

  2001cited by this paper
• Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNK-mediated signaling.

  2001cited by this paper
• Role of BAX in the apoptotic response to anticancer agents.

  2000cited by this paper
• The p53/p63/p73 family of transcription factors: overlapping and distinct functions.

  2000cited by this paper
• The Rb/E2F pathway: expanding roles and emerging paradigms.

  2000cited by this paper
• Dose-dependent inhibition of cell proliferation induced by lipid peroxidation products in rat hepatoma cells after enrichment with arachidonic acid

  1999cited by this paper
• Effects of mGST A4 transfection on 4-hydroxynonenal-mediated apoptosis and differentiation of K562 human erythroleukemia cells.

  1999cited by this paper
• Inhibition of D1, D2, and A-cyclin expression in HL-60 cells by the lipid peroxydation product 4-hydroxynonenal.

  1999cited by this paper
• p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

  1998cited by this paper
• Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F

  1998cited by this paper
• Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

  1997cited by this paper
• Modulation of human T lymphocyte proliferation by 4-hydroxynonenal, the bioactive product of neutrophil-dependent lipid peroxidation.

  1997cited by this paper
• Effect of 4-Hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells.

  1996cited by this paper
• The retinoblastoma protein pathway and the restriction point.

  1996cited by this paper
• A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation.

  1996cited by this paper
• Overexpression of the E2F-1 transcription factor gene mediates cell transformation.

  1995cited by this paper
• Role of the cyclin-dependent kinase inhibitors in the development of cancer.

  1995cited by this paper
• Enrichment with arachidonic acid increases the sensitivity of hepatoma cells to the cytotoxic effects of oxidative stress.

  1995cited by this paper
• Overexpression of the E2F-1 transcription factor gene mediates cell transformation.

  1995cited by this paper
• Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

  1994cited by this paper
• Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line.

  1994cited by this paper
• Overexpression of E2F‐1 in rat embryo fibroblasts leads to neoplastic transformation.

  1994cited by this paper
• Lipid peroxidation and cancer.

  1993cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• Mammalian G1 cyclins.

  1993cited by this paper
• TP53 tumor suppressor gene: A model for investigating human mutagenesis

  1992cited by this paper
• Association of human cyclin E with a periodic G1-S phase protein kinase.

  1992cited by this paper
• E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

  1992cited by this paper
• Animal cell cycles and their control.

  1992cited by this paper
• Retinoblastoma protein switches the E2F site from positive to negative element

  1992cited by this paper
• Cyclin A is required at two points in the human cell cycle.

  1992cited by this paper
• 4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 erythroleukemic cells.

  1992cited by this paper
• Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation.

  1991cited by this paper
• Role for cyclin A in the dependence of mitosis on completion of DMA replication

  1991cited by this paper
• The E2F transcription factor is a cellular target for the RB protein.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• p34cdc2: the S and M kinase?

  1990cited by this paper
• Effect of 4-Hydroxynonenal on c-myc Expression

  1987cited by this paper
• Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.

  1985cited by this paper

• Aldose reductase and cancer metabolism: The master regulator in the limelight.

  2023cites this paper
• Extracellular Vesicles under Oxidative Stress Conditions: Biological Properties and Physiological Roles

  2021cites this paper
• The relevance of pathophysiological alterations in redox signaling of 4-hydroxynonenal for pharmacological therapies of major stress-associated diseases.

  2019cites this paper
• Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.

  2019cites this paper
• Rutin as a Mediator of Lipid Metabolism and Cellular Signaling Pathways Interactions in Fibroblasts Altered by UVA and UVB Radiation

  2017cites this paper
• Effect of some phytoconstituents on Fe2+/ascorbate induced lipid peroxidation.

  2016cites this paper
• The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation.

  2016cites this paper
• On the role of 4-hydroxynonenal in health and disease.

  2015cites this paper
• Lipid peroxidation end product 4-hydroxy-trans-2-nonenal triggers unfolded protein response and heme oxygenase-1 expression in PC12 cells: Roles of ROS and MAPK pathways.

  2014cites this paper
• Phytic Acid Inhibits Lipid Peroxidation In Vitro

  2013influential citation
• Cell death and diseases related to oxidative stress:4-hydroxynonenal (HNE) in the balance

  2013cites this paper
• Free Radicals and Metabolic Disorders

  2012cites this paper
• Biphasic stress response in the soleus during reloading after hind limb unloading.

  2012cites this paper
• Regulation of Signal Transduction by Glutathione Transferases

  2012cites this paper
• Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function.

  2012cites this paper
• Signaling properties of 4-hydroxyalkenals formed by lipid peroxidation in diabetes.

  2012cites this paper
• Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells.

  2011cites this paper
• Growth modulation of human cells in vitro by mild oxidative stress and 1,4-dihydropyridine derivative antioxidants.

  2011cites this paper
• Cell Cycle Sensing of Oxidative Stress in Saccharomyces cerevisiae by Oxidation of a Specific Cysteine Residue in the Transcription Factor Swi6p*

  2010cites this paper
• Signaling and cytotoxic functions of 4-hydroxyalkenals.

  2010cites this paper
• Pathological aspects of lipid peroxidation

  2010cites this paper
• Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions.

  2009cites this paper
• Oxidation of Arachidonic and Docosahexaenoic Acids and Neurochemical Effects of Their Metabolites on Brain

  2009cites this paper
• Wpływ mocy dawki na komórkowe, biochemiczne i molekularne efekty promieniowania jonizującego* Dose rate-dependent cellular and molecular effects of ionizing radiation

  2008cites this paper
• Down-regulation of Notch1 expression is involved in HL-60 cell growth inhibition induced by 4-hydroxynonenal, a product of lipid peroxidation.

  2008cites this paper
• [Dose rate-dependent cellular and molecular effects of ionizing radiation].

  2008cites this paper
• 4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferase

  2008cites this paper
• The Effect of Photodynamic Treatment on the Levels of Aldehydic Lipid Peroxidation Products in Human Tumor Cells Wpływ reakcji fotodynamicznej na zawartość aldehydowych produktów peroksydacji lipidów w ludzkich komórkach nowotworowych

  2008cites this paper
• Aldehydic lipid peroxidation products in human brain astrocytomas

  2007cites this paper